lomerizine

This page covers all lomerizine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Voltage-dependent N-type calcium channel subunit alpha-1B.

Targets

Voltage-dependent N-type calcium channel subunit alpha-1B

Phase 2 pipeline (1)

• LOMERIZINE · Neuroscience
  Lomerizine works by blocking calcium channels in the brain to reduce excessive neuronal activity.

Patent intelligence

• lomerizine patent landscape — aggregated cliff calendar, attackable patents, originator estates